New PET probe aims to spot kidney cancer early
NCT ID NCT07590310
First seen May 16, 2026 · Last updated May 22, 2026 · Updated 2 times
Summary
This early-phase study tests a new PET imaging probe designed to detect clear cell renal cell carcinoma, a common type of kidney cancer. The probe targets a protein called CAIX, which is found in high levels on these cancer cells but not on most normal tissues. The goal is to see if this probe can accurately spot tumors throughout the body, potentially allowing for earlier and less invasive diagnosis. The study involves 3 participants with kidney cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital
RECRUITINGBeijing, Haidian, 10000, China
Conditions
Explore the condition pages connected to this study.